DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR LITHOBID
Clinical Trials for Lithobid
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00183443 | Treatment of Mania Symptoms With Drug Therapy | Completed | National Institute of Mental Health (NIMH) | Phase 3 | This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania. |
NCT00183443 | Treatment of Mania Symptoms With Drug Therapy | Completed | Palo Alto Veterans Institute for Research | Phase 3 | This study will determine the effectiveness of three different drug therapies in treating the symptoms of mania. |
NCT00601536 | Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions | Completed | Roxane Laboratories | N/A | The objective of this study was the bioequivalence of a Roxane lithium carbonate 300 mg extended release tablet formulation compared to Solvay's Lithobid 300 mg extended release tablet under fasting conditions using a single-dose, randomized, 2 treatment, 2-period, 2-sequence crossover design. |
Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Lithobid
Condition Name
Clinical Trial Locations for Lithobid
Trials by Country
Clinical Trial Progress for Lithobid
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Lithobid
Sponsor Name